Clinical Trial Update: Phase 1 Study of GSK2315698 in Healthy Japanese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study of GSK2315698 in healthy Japanese subjects has completed; amyloidosis is listed as the associated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Drugs mentioned

• GSK2315698

Snippet

Sponsor: GlaxoSmithKline | Conditions: Amyloidosis | Phase 1 | Status: COMPLETED